Latest News for: hodgkin

Edit

Lymphoma Therapeutics Strategic Business Research Report 2024-2030 by Non-Hodgkin Lymphoma, Hodgkin Lymphoma, Revlimid, Rituxan/MabThera, Imbruvica, ...

Nasdaq Globe Newswire 18 Mar 2025
Dublin, March 18, 2025 (GLOBE NEWSWIRE) -- The "Lymphoma Therapeutics - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering ... The growth in the lymphoma therapeutics market is driven by several factors ... .
Edit

CAR T-Cell Therapy for Non-Hodgkin’s lymphoma Market to Reach New Heights in Growth by 2034, ...

GetNews 06 Mar 2025
This report is an essential resource for understanding the market dynamics and the evolving therapeutic options within the CAR T-Cell Therapy for Non-Hodgkin’s lymphoma space ... Key CAR T-Cell Therapy for Non-Hodgkin’s lymphoma Companies.
Edit

Foresight Diagnostics Launches PRECISE-HL Trial to Explore ctDNA-Based Therapy De-Escalation in Classical Hodgkin Lymphoma (cHL)

PR Newswire 05 Mar 2025
Personalized Reduction of Chemotherapy Intensity Through ctDNA Evaluation in Advanced Hodgkin Lymphoma ... "Nivolumab+AVD in Advanced-Stage Classic Hodgkin's Lymphoma." ... "Concurrent pembrolizumab with AVD for untreated classic Hodgkin lymphoma."
Edit

B-Cell Non-Hodgkin Lymphoma Pipeline 2024: MOA, ROA, and Clinical Trial Insights Explored by DelveInsight | ...

GetNews 05 Mar 2025
“" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the B-Cell Non-Hodgkin Lymphoma Market ... B-Cell Non-Hodgkin Lymphoma Overview.
Edit

Shanghai Gallery BANK Is Set to Land in New York City

New York Observer 04 Mar 2025
BANK NYC will open at 127 Elizabeth Street. Courtesy of BANK ... waters with a pilot space in New York ... Sign Up ... Its inaugural show in China featured Paul McCarthy, Roxy Paine, Zhang Enli and Howard Hodgkin—setting the tone for its cross-cultural mission ... .
  • 1
×